RCUS
Arcus Biosciences, Inc. · Healthcare
Chief Medical Officer Richard Markus sold $210K of Arcus Biosciences, Inc.
Sold$210,144
$22.01Price
9,546Shares
−13%Stake
What RCUS did after the filing
- The stock from Thu, Dec 18 close, $21.99
- −0.1%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Feb 3 close.
Traded Tue, Dec 16. Filed Thu, Dec 18, 12:35 PM ET, during the session. Returns use the Dec 18 close and the Feb 3 close. Not investment advice.